Jonathan Brouillette - Publications, H-index & Citations

Jonathan Brouillette

University of Montreal

21H指数

53论文数

1.7K被引数

收录论文 17

发表时间

Electrocorticographic, Astrocytic and Transcriptomic Signatures in the Triple Transgenic Mouse Model of Alzheimer's Disease submitted to Stearoyl-CoA Desaturase Inhibition 皮层脑电、星形胶质细胞和转录组学特征：在经硬脂酰辅酶A去饱和酶抑制的阿尔茨海默病三转基因小鼠模型中

Neuropharmacology

IF4.6

2026-01-13

PREAI

Audrey Hector; Tanya Leduc; Maria João da Costa Caiado; Benoît Delignat-Lavaud; Julien Dufort-Gervais; Caroline Daneault; Christine Des Rosiers; Clément Bourguignon; Jean-Marc Lina; Karl Fernandes; Jonathan Brouillette; Valérie Mongrain

Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2023-10-13

OAAI

Hector, Audrey; Provost, Chloe; Delignat-Lavaud, Benoit; Bouamira, Khadija; Menaouar, Chahinez-Anissa; Mongrain, Valerie; Brouillette, Jonathan

Implication of tau propagation on neurodegeneration in Alzheimer's disease tau蛋白传播对阿尔茨海默病神经退行性变的影响

FRONTIERS IN NEUROSCIENCE

IF3.2

2023-07-07

OAAI

Lamontagne-Kam, Daniel; Ulfat, Anosha Kiran; Herve, Vincent; Vu, Tra-My; Brouillette, Jonathan

Impact of non-neuronal cells in Alzheimer's disease from a single-nucleus profiling perspective 从单核轮廓分析角度看非神经元细胞对阿尔茨海默病的影响

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2023-06-14

OAAI

Vu, Tra-My; Herve, Vincent; Ulfat, Anosha Kiran; Lamontagne-Kam, Daniel; Brouillette, Jonathan

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2021-01-07

OAAI

Hector, Audrey; Brouillette, Jonathan

Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers

SCIENTIFIC REPORTS

IF3.9

2020-04-24

OAAI

Dufort-Gervais, Julien; Provost, Chloe; Charbonneau, Laurence; Norris, Christopher M.; Calon, Frederic; Mongrain, Valerie; Brouillette, Jonathan

Tau hyperphosphorylation induced by the anesthetic agent ketamine/xylazine involved the calmodulin-dependent protein kinase II

FASEB JOURNAL

IF4.2

2019-12-26

OAAI

Hector, Audrey; McAnulty, Christina; Piche-Lemieux, Maude-Eloise; Alves-Pires, Claire; Buee-Scherrer, Valerie; Buee, Luc; Brouillette, Jonathan

The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline

CURRENT BIOLOGY

IF7.5

2018-04-01

OAAI

Castonguay, David; Dufort-Gervais, Julien; Menard, Caroline; Chatterjee, Manavi; Quirion, Remi; Bontempi, Bruno; Schneider, Jay S.; Arnsten, Amy F. T.; Nairn, Angus C.; Norris, Christopher M.; Ferland, Guylaine; Bezard, Erwan; Gaudreau, Pierrette; Lombroso, Paul J.; Brouillette, Jonathan

The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications

TRANSLATIONAL PSYCHIATRY

IF6.2

2012-07-10

OAAI

Carty, N. C.; Xu, J.; Kurup, P.; Brouillette, J.; Goebel-Goody, S. M.; Austin, D. R.; Yuan, P.; Chen, G.; Correa, P. R.; Haroutunian, V.; Pittenger, C.; Lombroso, P. J.

Tau Phosphorylation and Sevoflurane Anesthesia An Association to Postoperative Cognitive Impairment

ANESTHESIOLOGY

IF9.1

2012-04-01

194

OAAI

Le Freche, Helene; Brouillette, Jonathan; Fernandez-Gomez, Francisco-Jose; Patin, Pauline; Caillierez, Raphaelle; Zommer, Nadege; Sergeant, Nicolas; Buee-Scherrer, Valerie; Lebuffe, Gilles; Blum, David; Buee, Luc

Physiopathological features of tauopathies and tau transgenic mice

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2010-08-01

PREAI

Buee, L.; Burnouf, S.; Troquier, L.; Leboucher, A.; Laurent, C.; Le Freche, H.; Brouillette, J.; Hamdane, M.; Sergeant, N.; Blum, D.

Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice

NEUROBIOLOGY OF DISEASE

IF5.6

2009-09-01

113

PREAI